These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17348603)

  • 1. What you need to know about the new regulations for biomedical research in France.
    Tillet Y; Lebrun A
    Therapie; 2006; 61(6):463-70. PubMed ID: 17348603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What you Need to Know about the New Regulations for Biomedical Research in France.
    Tillet Y; Lebrun A
    Therapie; 2006; 61(6):467-70. PubMed ID: 27393047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The adoption of Jardé law modifies the legal framework of clinical research in France].
    Maillols-Perroy AC; Tillet Y
    Therapie; 2012; 67(2):77-87. PubMed ID: 22850095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ethical and juridical context of the facial allotransplant].
    Meningaud JP
    Ann Chir Plast Esthet; 2007 Oct; 52(5):513-8. PubMed ID: 17597281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conduct of clinical trials for medicinal products in europe in the light of the European clinical trials directive. Review of regulatory and practical aspects in the different countries.
    Dubray C; Maillere P; Spriet A;
    Therapie; 2007; 62(3):193-7, 199-202. PubMed ID: 17803885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Committee for the protection of persons.
    Brion N; Demarez JP; Belorgey C;
    Therapie; 2005; 60(4):319-28, 329-37. PubMed ID: 16268433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of the clinical trials directive: recommendations on the contents of a dossier for the request for authorisation of the first trials in human subjects.
    Bélorgey C; Plétan Y; Goehrs JM;
    Therapie; 2004; 59(3):329-47. PubMed ID: 15559187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biomedical research in France: what has changed since 2004].
    Clerget-Chossat N; Caillaud T; Elena PP
    J Fr Ophtalmol; 2008 Jan; 31(1):80-6. PubMed ID: 18401305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. French legal approach to clinical research.
    Toulouse E; Masseguin C; Lafont B; McGurk G; Harbonn A; A Roberts J; Granier S; Dupeyron A; Bazin JE
    Anaesth Crit Care Pain Med; 2018 Dec; 37(6):607-614. PubMed ID: 30580775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Emergence of norms for biomedical research. At the origin of the Huriet law (1975-1988)].
    Léchopier N
    Med Sci (Paris); 2004 Mar; 20(3):377-81. PubMed ID: 15067587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Round table 2. The evolutions following the implementation of the law for health and sanitary security].
    Med Sci (Paris); 2014 Apr; 30 Spe(1):14-20. PubMed ID: 24755172
    [No Abstract]   [Full Text] [Related]  

  • 12. [Harmonisation of regulatory requirements for clinical trials on medicinal products for human use in the Directive 2001/20/EC and complementary guidance. Implementation of the 12th Law Amending the German Drug Law].
    Geisler I; Hofmann HP; Nickel L
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):141-6. PubMed ID: 15726454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroscience in the Courtroom: From responsibility to dangerousness, ethical issues raised by the new French law].
    Gkotsi GM; Moulin V; Gasser J
    Encephale; 2015 Oct; 41(5):385-93. PubMed ID: 25439859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New legislation about clinical research involving "usual care": reminder of recent problems].
    Lemaire F; Schortgen F; Chastre J; Fagon JY; Brochard L; Lacherade JC; Becquemin JP; Brun-Buisson C
    Presse Med; 2007 Sep; 36(9 Pt 1):1167-73. PubMed ID: 17521859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A national debate to prepare the 2018 French bioethics law].
    Chneiweiss H
    Med Sci (Paris); 2018 Feb; 34(2):107-108. PubMed ID: 29451474
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evolution of the regulatory framework in clinical research].
    Vanseymortier M; Thery J; Penel N
    Bull Cancer; 2019 Apr; 106(4):389-394. PubMed ID: 30885366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulations on gases for medical use in France].
    Poitou P; Fouret C; Duffau E
    Ann Pharm Fr; 2002 Sep; 60(5):326-32. PubMed ID: 12378142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creating conditions for the success of the French industrial advanced therapy sector.
    Lirsac PN; Blin O; Magalon J; ; Angot P; de Barbeyrac E; Bilbault P; Bourg E; Damour O; Faure P; Ferry N; Garbil B; Larghero J; Nguon M; Pattou F; Thumelin S; Yates F
    Therapie; 2015; 70(1):69-94. PubMed ID: 25747840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The system of protection of scientific biomedical research participants in France and in Poland].
    Czarkowski M; Sieczych A
    Pol Merkur Lekarski; 2013 Jul; 35(205):55-8. PubMed ID: 23984608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cosmetovigilance: a French pharmacovigilance system for cosmetics developed by the French health products safety agency. A proposal for the future].
    Tissier MH; Lepagnol F
    Therapie; 2002; 57(3):273-82. PubMed ID: 12422542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.